To this end, we peripherally injected Cx3cr1CreERT2R26Confetti5×FAD+ mice and controls with the CSF1R ligands Csf1 or interleukin (IL)-34 at early stages of amyloid pathology (Extended Data Fig. 5a). The gene discussed is CSF1R; the disease is amyloidosis.